Institutional investors purchased a net $7.3 million shares of CVM during the quarter ended September 2015. This may signal that the smart money is gaining interest in this company as the 10.21% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREATIVE PLANNING, INC. Bought 32.3 Thousand shares of CEL-SCI Corp